international
Is there anything GLP-1 agonist drugs cannot do?
Key takeaways
- Every other month, researchers find new uses for GLP-1 agonist drugs, like Mounjaro and Ozempic — now even as a treatment for substance abuse.
- https://p.dw.com/p/5FB98Doctors are warning of a new weight-loss injection craze that is reshaping bridal beauty pressure Image: Niall Carson/empics/picture alliance Advertisement.
- There's also evidence that GLP-1 agonists, like semaglutide and tirzepatide — sold as Mounjaro, Ozempic, Wegovy and Zepound —
Why this matters: an international story with cross-border implications worth tracking.
Every other month, researchers find new uses for GLP-1 agonist drugs, like Mounjaro and Ozempic — now even as a treatment for substance abuse. It's classic drug repurposing, a technique that saved lives during COVID.
https://p.dw.com/p/5FB98Doctors are warning of a new weight-loss injection craze that is reshaping bridal beauty pressure Image: Niall Carson/empics/picture alliance Advertisement. The list of uses for GLP-1 agonist drugs keeps growing: It started as a treatment for type 2 diabetes, then got hyped as a weight-loss jab.
There's also evidence that GLP-1 agonists, like semaglutide and tirzepatide — sold as Mounjaro, Ozempic, Wegovy and Zepound —
Article preview — originally published by DW English. Full story at the source.
Read full story on DW English →
More top stories
Aggregated and edited by the Scoop newsroom. We surface news from DW English alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop